These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3666104)

  • 1. Specific binding of B-CLL cell-derived chemokinetic inhibitory factor (CIF) to human polymorphonuclear leukocytes.
    Siegbahn A; Garcia RC; Kishi K; Nilsson K; Venge P
    Eur J Haematol; 1987 Aug; 39(2):172-9. PubMed ID: 3666104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of chemokinetic inhibitory factor (CIF) by normal blood and spleen B lymphocytes.
    Siegbahn A; Rosén A; Venge P; Aman P; Nilsson K
    Leuk Res; 1986; 10(2):179-86. PubMed ID: 3485223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemokinetic inhibitory factor (CIF) in serum of CLL patients: correlation with infection propensity and disease activity.
    Siegbahn A; Simonsson B; Venge P
    Scand J Haematol; 1985 Jul; 35(1):80-7. PubMed ID: 3901243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific binding of leukocyte inhibitory factor to neutrophil plasma membranes.
    Klempner MS; Rocklin RE
    J Immunol; 1982 May; 128(5):2040-3. PubMed ID: 7037959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum inhibitory factor for guinea pig macrophage and neutrophil chemotaxis found in cancer patients.
    Miyahara T; Torisu M
    Gan; 1981 Dec; 72(6):854-61. PubMed ID: 7341335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a chemokinetic inhibitor in serum from patients with chronic lymphocytic leukaemia.
    Siegbahn A; Venge P; Nilsson K; Simonson B
    Scand J Haematol; 1982 Feb; 28(2):122-31. PubMed ID: 7046030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil migration inhibition factor from T lymphocytes (NIF-T): selective removal of biologic activity by human peripheral blood neutrophils, myelocytic leukemia cells, and differentiated HL-60 cells.
    Weisbart RH; Lusis AJ; Chan G; Billing R; Ashman RF; Golde DW
    J Immunol; 1982 Jan; 128(1):457-62. PubMed ID: 6976379
    [No Abstract]   [Full Text] [Related]  

  • 8. Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization.
    Hunninghake GW; Gadek JE; Fales HM; Crystal RG
    J Clin Invest; 1980 Sep; 66(3):473-83. PubMed ID: 6995485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific binding, internalization, and degradation of human neutrophil activating factor by human polymorphonuclear leukocytes.
    Besemer J; Hujber A; Kuhn B
    J Biol Chem; 1989 Oct; 264(29):17409-15. PubMed ID: 2677006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement C4-derived monocyte-directed chemotaxis-inhibitory factor. A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities.
    Matsubara S; Yamamoto T; Tsuruta T; Takagi K; Kambara T
    Am J Pathol; 1991 May; 138(5):1279-91. PubMed ID: 2024711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemokinetic inhibitory factor derived from chronic lymphocytic leukaemia cells. Partial purification and characterization of a new lymphokine.
    Siegbahn A; Nilsson K; Venge P
    Scand J Immunol; 1986 Jan; 23(1):15-23. PubMed ID: 3704559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elastase controls the binding of the vitamin D-binding protein (Gc-globulin) to neutrophils: a potential role in the regulation of C5a co-chemotactic activity.
    DiMartino SJ; Shah AB; Trujillo G; Kew RR
    J Immunol; 2001 Feb; 166(4):2688-94. PubMed ID: 11160333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte-macrophage colony-stimulating factor is a chemoattractant cytokine for human neutrophils: involvement of the ribosomal p70 S6 kinase signaling pathway.
    Gomez-Cambronero J; Horn J; Paul CC; Baumann MA
    J Immunol; 2003 Dec; 171(12):6846-55. PubMed ID: 14662891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective calcium influx factor activity in neutrophils from patients with localized juvenile periodontitis.
    Shibata K; Warbington ML; Gordon BJ; Kurihara H; Van Dyke TE
    J Periodontol; 2000 May; 71(5):797-802. PubMed ID: 10872962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The myeloid leukemia cell line HL-60 produces a factor that induces chloride secretion in cultured epithelial cells.
    Colgan SP; Matthews JB; Parkos CA; Delp C; Awtrey CS; Madara JL
    J Leukoc Biol; 1992 Aug; 52(2):183-7. PubMed ID: 1506774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of thrombospondin receptor expression during HL-60 cell differentiation.
    Suchard SJ; Mansfield PJ; Dixit VM
    J Immunol; 1994 Jan; 152(2):877-88. PubMed ID: 7506739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal adaptation of neutrophil oxidative responsiveness to n-formyl-methionyl-leucyl-phenylalanine. Acceleration by granulocyte-macrophage colony stimulating factor.
    English D; Broxmeyer HE; Gabig TG; Akard LP; Williams DE; Hoffman R
    J Immunol; 1988 Oct; 141(7):2400-6. PubMed ID: 3049807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte inhibitory factor (LIF): a lymphocyte mediator with esteratic properties.
    Rocklin R
    Fed Proc; 1978 Nov; 37(13):2743-7. PubMed ID: 710595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascorbic acid modulates cell migration in differentiated HL-60 cells and peripheral blood leukocytes.
    Schwager J; Bompard A; Weber P; Raederstorff D
    Mol Nutr Food Res; 2015 Aug; 59(8):1513-23. PubMed ID: 25808314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokinetic and chemotactic factors in psoriasis scale extracts.
    Dahl MV; Lindroos WE; Nelson RD
    J Invest Dermatol; 1978 Dec; 71(6):402-6. PubMed ID: 722120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.